Associations between urate-lowering therapy and the risk of type 2 diabetes mellitus.
<h4>Background</h4>Gout is independently associated with increased risk of type 2 diabetes mellitus (T2DM). Urate-lowering therapy (ULT) might be beneficial in lowering the risks of T2DM. Therefore, we conducted a nested case-control study to evaluate the associations between ULT and T2D...
Main Authors: | Hsin-Wen Chang, Ya-Wen Lin, Ming-Hung Lin, Yu-Ching Lan, Ruey-Yun Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2019-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0210085 |
Similar Items
-
Association between Gout, Urate-Lowering Therapy, and Risk of Developing Type 2 Diabetes Mellitus: A Nationwide Population-Based Retrospective Cohort Study
by: Yi-Jen Fang, et al.
Published: (2020-01-01) -
Variation in serum urate levels in the absence of gout and urate lowering therapy
by: Andrew Shaffer, et al.
Published: (2021-09-01) -
Urate-lowering therapy for heart failure
by: O. V. Zhelyabina, et al.
Published: (2019-09-01) -
Levels of LDL-cholesterol, Triglyceride and Urate in Patients With Type 2 Diabetes Mellitus
by: Dunja Šojat, et al.
Published: (2020-04-01) -
Urate-lowering therapy may mitigate the risks of hospitalized stroke and mortality in patients with gout.
by: Fu-Shun Yen, et al.
Published: (2020-01-01)